Steroids and drotrecogin alfa (activated) for severe sepsis

被引：0
|
作者：
Steingrub, JS [1 ]
机构：
[1] Baystate Med Ctr, Med ICU, Springfield, MA 01199 USA
来源：
CHEST | 2003年 / 124卷 / 05期
关键词：
D O I：
10.1378/chest.124.5.2033
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2033 / 2033
页数：1
相关论文
共 50 条
  • [31] Drotrecogin alfa (activated) - A pharmacoeconomic review of its use in severe sepsis
    Frampton, JE
    Foster, RH
    PHARMACOECONOMICS, 2004, 22 (07) : 445 - 476
  • [32] Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis
    Levy, H
    Small, D
    Heiselman, DE
    Riker, R
    Steingrub, J
    Chen, RQ
    Qualy, RL
    Darstein, C
    Mongan, E
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 262 - 267
  • [33] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    Abraham, E
    Laterre, P
    Garg, R
    Levy, H
    Talwar, D
    Trzaskoma, BL
    Francois, B
    Guy, JS
    Bruckmann, M
    Rea-Neto, A
    Rossaint, R
    Perrotin, D
    Sablotzki, A
    Arkins, N
    Utterback, BG
    Macias, WL
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13): : 1332 - 1341
  • [34] Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis
    Launois, R
    Riou-Franca, L
    Guidet, B
    Aergeter, P
    Meshaka, P
    Pinton, P
    INTENSIVE CARE MEDICINE, 2002, 28 : S161 - S161
  • [35] Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death
    Jan O Friedrich
    Neill KJ Adhikari
    Maureen O Meade
    Critical Care, 10
  • [36] Drotrecogin Alfa (Activated)A Pharmacoeconomic Review of its Use in Severe Sepsis
    James E. Frampton
    Rachel H. Foster
    PharmacoEconomics, 2004, 22 : 445 - 476
  • [37] Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death
    Friedrich, Jan O.
    Adhikari, Neill K. J.
    Meade, Maureen O.
    CRITICAL CARE, 2006, 10 (06)
  • [38] Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis
    Dhainaut, JF
    AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 5S - 10S
  • [39] Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsis
    Olsen, KM
    Martin, SJ
    PHARMACOTHERAPY, 2002, 22 (12): : 196S - 205S
  • [40] Drotrecogin alfa (activated) effects in patients with severe sepsis with or without DIC
    Dhainaut, J
    Yan, B
    INTENSIVE CARE MEDICINE, 2003, 29 : S88 - S88
12345